Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy

被引:89
作者
Dong, Yuancai
Feng, Si-Shen
机构
[1] Natl Univ Singapore, Fac Engn, Dept Chem & Biomol Engn, Singapore 117576, Singapore
[2] Natl Univ Singapore, Fac Engn, Dept Bioengn, Singapore 117576, Singapore
关键词
anticancer drugs; cancer nanotechnology; chemotherapeutic engineering; paclitaxel; nanobiotechnology; nanomedicine;
D O I
10.1016/j.ijpharm.2007.04.031
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
High pressure homogenization was employed in the current work to prepare poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs) for controlled release of paclitaxel. The prepared drug-loaded PLGA NPs were found of spherical shape with a size of 200-300nm. The drug encapsulation efficiency ranged from 34.8 +/- 1.6 to 62.6 +/- 7.9% depending on the homogenization pressure and cycles. Paclitaxel was released from the nanoparticles in a biphasic profile with a fast release rate in the first 3 days followed by a slow first-order release. A higher or comparable cytotoxicity against glioma C6 cells was found for the drug formulated in the PLGA NPs in comparison with the free drug Taxol(R). Confocal laser scanning microscopy (CLSM) evidenced internalization of the fluorescent coumarin 6-loaded PLGA NPs by the C6 cells. The freeze-dried nanoparticles were found to possess excellent water redispersability. The high pressure homogenization could be applied for large industrial scale production of nanoparticles for drug delivery. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:208 / 214
页数:7
相关论文
共 37 条
[1]   PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Karydas, AG ;
Ithakissios, DS .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :123-135
[2]   Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[3]   Poly(hydroxyethyl aspartamide) derivatives as colloidal drug carrier systems [J].
Cavallaro, G ;
Licciardi, M ;
Giammona, G ;
Caliceti, P ;
Semenzato, A ;
Salmaso, S .
JOURNAL OF CONTROLLED RELEASE, 2003, 89 (02) :285-295
[4]   Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics [J].
Chorny, M ;
Fishbein, I ;
Danenberg, HD ;
Golomb, G .
JOURNAL OF CONTROLLED RELEASE, 2002, 83 (03) :389-400
[5]   Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs [J].
Dong, YC ;
Feng, SS .
BIOMATERIALS, 2004, 25 (14) :2843-2849
[6]   New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? [J].
Feng, Si-Shen .
NANOMEDICINE, 2006, 1 (03) :297-309
[7]   Nanoparticles of biodegradable polymers for clinical administration of paclitaxel [J].
Feng, SS ;
Mu, L ;
Win, KY ;
Huang, GF .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (04) :413-424
[8]   Nonoparticles of biodegradable polymers for new-concept chemotherapy [J].
Feng, SS .
EXPERT REVIEW OF MEDICAL DEVICES, 2004, 1 (01) :115-125
[9]   Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases [J].
Feng, SS ;
Chien, S .
CHEMICAL ENGINEERING SCIENCE, 2003, 58 (18) :4087-4114
[10]   Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers [J].
Feng, SS ;
Huang, GF .
JOURNAL OF CONTROLLED RELEASE, 2001, 71 (01) :53-69